91 related articles for article (PubMed ID: 23514668)
1. Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis.
Ma H; Wu Y; Xu Y; Sun L; Zhang X
Am J Med Sci; 2013 Dec; 346(6):486-93. PubMed ID: 23514668
[TBL] [Abstract][Full Text] [Related]
2. [Transplantation of human umbilical cord mesenchymal stem cells alleviates the progression of FSGS in rats].
Ma H; Zhang W; Dai Y; Li F; Wu Y; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):150-3. PubMed ID: 23388334
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models.
Yang RC; Zhu XL; Wang J; Wan F; Zhang HQ; Lin Y; Tang XL; Zhu B
BMC Nephrol; 2018 Nov; 19(1):335. PubMed ID: 30466397
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB.
Song IH; Jung KJ; Lee TJ; Kim JY; Sung EG; Bae YC; Park YH
Nephrology (Carlton); 2018 May; 23(5):483-492. PubMed ID: 28326639
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.
Semedo P; Correa-Costa M; Antonio Cenedeze M; Maria Avancini Costa Malheiros D; Antonia dos Reis M; Shimizu MH; Seguro AC; Pacheco-Silva A; Saraiva Camara NO
Stem Cells; 2009 Dec; 27(12):3063-73. PubMed ID: 19750536
[TBL] [Abstract][Full Text] [Related]
6. The effect of mesenchymal stromal cells on doxorubicin-induced nephropathy in rats.
Ma H; Wu Y; Zhang W; Dai Y; Li F; Xu Y; Wang Y; Tu H; Li W; Zhang X
Cytotherapy; 2013 Jun; 15(6):703-11. PubMed ID: 23499348
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin attenuates the severity of murine adriamycin nephropathy.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
[TBL] [Abstract][Full Text] [Related]
9. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
Lee VW; Harris DC
Nephrology (Carlton); 2011 Jan; 16(1):30-8. PubMed ID: 21175974
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis.
Belingheri M; Lazzari L; Parazzi V; Groppali E; Biagi E; Gaipa G; Giordano R; Rastaldi MP; Croci D; Biondi A; Rebulla P; Edefonti A; Ghio L
Biologicals; 2013 Nov; 41(6):439-45. PubMed ID: 24135082
[TBL] [Abstract][Full Text] [Related]
11. Glomerulosclerosis 4 weeks after administration of adriamycin in a single dose.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):214-9. PubMed ID: 16145983
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin-converting enzyme 2 is superior for the treatment of acute lung ischemia-reperfusion injury in rats.
Zhang X; Gao F; Yan Y; Ruan Z; Liu Z
Cell Biochem Funct; 2015 Apr; 33(3):113-20. PubMed ID: 25756848
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
[TBL] [Abstract][Full Text] [Related]
14. Protection by Chinese herbs against Doxorubicin-induced focal and segmental glomerulosclerosis in rats.
Tong Y; Wang Q; Hou H
Drug Dev Ind Pharm; 2008 Jul; 34(7):663-7. PubMed ID: 18608470
[TBL] [Abstract][Full Text] [Related]
15. [Alpha-mangostin attenuates focal segmental glomerulosclerosis of mice induced by adriamycin].
Liu G; Tang L; She J; Xu J; Gu Y; Liu H; He L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1089-1096. PubMed ID: 30523229
[TBL] [Abstract][Full Text] [Related]
16. Astaxanthin attenuates adriamycin-induced focal segmental glomerulosclerosis.
Liu G; Shi Y; Peng X; Liu H; Peng Y; He L
Pharmacology; 2015; 95(3-4):193-200. PubMed ID: 25924598
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155-5p Aggravates Adriamycin-Induced Focal Segmental Glomerulosclerosis through Targeting Nrf2.
Liu G; He L; Yang X; Tang L; Shi W; She J; Wei J
Nephron; 2023; 147(2):108-119. PubMed ID: 35728579
[TBL] [Abstract][Full Text] [Related]
18. Icariin combined with human umbilical cord mesenchymal stem cells significantly improve the impaired kidney function in chronic renal failure.
Li W; Wang L; Chu X; Cui H; Bian Y
Mol Cell Biochem; 2017 Apr; 428(1-2):203-212. PubMed ID: 28116543
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.
Liu G; Wang Q; Shi Y; Peng X; Liu H; Peng Y; He L
Pharmacology; 2017; 100(5-6):253-260. PubMed ID: 28797008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
